Cargando…

Nucleic Acid Targeting: Towards Personalized Therapy for Head and Neck Cancer

In light of a detailed characterization of genetic aberrations in cancer, nucleic acid targeting represents an attractive therapeutic approach with significant translational potential. Head and neck squamous cell carcinoma (HNSCC) is a leading cause of cancer deaths worldwide with stagnant 5-year su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parsel, Sean M, Grandis, Jennifer R, Thomas, Sufi M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877278/ https://www.ncbi.nlm.nih.gov/pubmed/26592450 http://dx.doi.org/10.1038/onc.2015.424

Ejemplares similares

Nucleic acid-based approaches to STAT inhibition
por: Sen, Malabika, et al.
Publicado: (2012)

Activated HGF-c-Met Axis in Head and Neck Cancer
por: Arnold, Levi, et al.
Publicado: (2017)

Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors
por: Egloff, Ann Marie, et al.
Publicado: (2009)

Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation
por: Suzuki, Shinsuke, et al.
Publicado: (2010)

Quantitative clinical outcomes of therapy for head and neck lymphedema
por: Doke, Kaleigh N., et al.
Publicado: (2018)

Genomically personalized therapy in head and neck cancer
por: Aung, Kyaw L., et al.
Publicado: (2016)

Targeted therapy in head/neck and gastric cancers
por: Hsueh, Chung-Tsen
Publicado: (2012)

Head and Neck Cancer among American Indian and Alaska Native Populations in California, 2009–2018
por: Warren, Brooke R., et al.
Publicado: (2021)

MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer
por: Chapman, Bhavana V., et al.
Publicado: (2015)

Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted Therapy
por: Dai, Hong, et al.
Publicado: (2022)

Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer
por: Peyser, Noah D., et al.
Publicado: (2016)

Personalized cancer vaccination in head and neck cancer
por: Shibata, Hirofumi, et al.
Publicado: (2021)

Challenges in EGFRvIII Detection in Head and Neck Squamous Cell Carcinoma
por: Wheeler, Sarah E., et al.
Publicado: (2015)

Therapeutic implications of transcriptomics in head and neck cancer patient-derived xenografts
por: Lee, Rex H., et al.
Publicado: (2023)

Identification of Mutations in the PYRIN-Containing NLR Genes (NLRP) in Head and Neck Squamous Cell Carcinoma
por: Lei, Yu, et al.
Publicado: (2014)

Targeting Head and Neck Cancer by Vaccination
por: Wang, Chuan, et al.
Publicado: (2018)

Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy
por: Xie, Bingteng, et al.
Publicado: (2022)

Receptor-Tyrosine-Kinase-Targeted Therapies for Head and Neck Cancer
por: Elferink, Lisa A., et al.
Publicado: (2011)

Dermatologic Toxicities of Targeted Therapy and Immunotherapy in Head and Neck Cancers
por: Espinosa, Maria L., et al.
Publicado: (2021)

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers
por: Taghizadeh, Hossein, et al.
Publicado: (2020)

Nucleic Acids in Cancer Diagnosis and Therapy
por: Kim, Taewan
Publicado: (2020)

Nucleic Acids in Cancer Diagnosis and Therapy
por: Kim, Taewan
Publicado: (2023)

NALDB: nucleic acid ligand database for small molecules targeting nucleic acid
por: Kumar Mishra, Subodh, et al.
Publicado: (2016)

CRISPR/Cas systems for the detection of nucleic acid and non-nucleic acid targets
por: Su, Weiran, et al.
Publicado: (2023)

Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer—A Step before Anakoinosis-Based Personalized Treatment
por: Kleszcz, Robert
Publicado: (2023)

Boron neutron capture therapy: moving towards targeted therapy for locally recurrent head and neck squamous cell carcinoma
por: Sun, Ying
Publicado: (2019)

Circulating cell-free nucleic acids as potential biomarkers for sarcopenia: a step toward personalized medicine
por: Shafiee, Gita, et al.
Publicado: (2017)

Stability and mechanism of threose nucleic acid toward acid-mediated degradation
por: Lee, Erica M, et al.
Publicado: (2023)

Targeted high-throughput sequencing of tagged nucleic acid samples
por: Meyer, Matthias, et al.
Publicado: (2007)

Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology
por: Hesse, Jennifer, et al.
Publicado: (2022)

Prospects for Antisense Nucleic Acid Therapy of Cancer and AIDS
por: Tidd, D.M.
Publicado: (1993)

NSAIDs Overcome PIK3CA Mutation-Mediated Resistance to EGFR Inhibition in Head and Neck Cancer Preclinical Models
por: Li, Hua, et al.
Publicado: (2022)

Molecular targeted therapies in head and neck cancer - An update of recent developements -
por: Goerner, Martin, et al.
Publicado: (2010)

mTOR co-targeting strategies for head and neck cancer therapy
por: Wang, Zhiyong, et al.
Publicado: (2017)

Progress of molecular targeted therapy for head and neck cancer in clinical aspects
por: Nakano, Kenji
Publicado: (2021)

Targeted therapy for head and neck cancer: signaling pathways and clinical studies
por: Li, Qingfang, et al.
Publicado: (2023)

STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors
por: Ramasamy, Thiruganesh, et al.
Publicado: (2020)

Targeted Iron-Oxide Nanoparticle for Photodynamic Therapy and Imaging of Head and Neck Cancer
por: Wang, Dongsheng, et al.
Publicado: (2014)

APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma
por: Cannataro, Vincent L., et al.
Publicado: (2019)

Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
por: Fu, Zhaoying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rkcpljtm5rvkjr0hen8kj3h4pf